Patis, Jomar L.

HRN: 27-26-01  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2026
CEFTRIAXONE 1G (VIAL)
03/03/2026
03/10/2026
IV
2g
OD
Lacerated Wound And Abrasions
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: